Thursday 11 July at 15:00 [BST]
Online panel discussion/webinar. Register here.
CRISPR has demonstrated its ability to edit DNA in bacteria, viruses, plants and human cells. It is proving itself to have many advantages over other gene editing techniques, including its simplicity, efficiency, easy customization of target DNA and the ability to target multiple genes simultaneously. Novel CRISPR systems and applications are continuously being developed, so its potential is ever-growing.
However, CRISPR is not currently perfect and does not come without its concerns. CRISPR can often affect regions of DNA outside of its target, hence continuous evaluation and technique development is necessary. Therefore, there are also huge ethical issues with utilizing CRISPR editing on humans, on top of the question of whether gene editing on humans is moral in the first place.
In this free panel discussion, our experts will discuss the latest developments and challenges with using CRISPR and what the future holds for the much-discussed technique.
Helen O’Neill, Lecturer in Reproductive and Molecular Genetics, UCL (London)
Gaetan Burgio, Group Leader and Head of the Transgenesis Facility, ANU College of Health and Medicine (Australia)
Felicity Boardman, Associate Professor, Warwick Medical School (UK)
Jonathan Pugh, Research Fellow, University of Oxford (UK)